Clinical Trial

The Role of Maspin in Colorectal Carcinoma, an Immunohistochemical Study

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Colorectal carcinoma (CRC) is a common cancer that arises from genetic and epigenetic changes in colon stem cells. The protein maspin acts as a tumor suppressor, influencing cell adhesion, motility, apoptosis, and angiogenesis. Its role varies by localization within cells; cytoplasmic maspin is associated with low metastatic risk, while nuclear maspin is linked to early recurrence in advanced CRC. Maspin's function can be either tumor-suppressive or oncogenic, depending on its expression and methylation status. Further research is needed to fully understand its prognostic significance in CRC.
Trial Details
NCT Number NCT06915350
Lead Sponsor Assiut University
Conditions Maspin in Colorectal Carcinoma
Enrollment 50 participants
Start Date 2025-08
Primary Completion 2028-09 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-08